{"slug":"preventive-vaccine","tag":"preventive-vaccine","variants":["preventive-vaccine"],"description":"No description yet","count":13,"kinds":{"drug":13},"related":[{"slug":"hepatitis-b-vaccine","tag":"hepatitis-b-vaccine","shared":10},{"slug":"hpv-vaccine","tag":"hpv-vaccine","shared":3}],"records":[{"id":"engerix-b","kind":"drug","name":"Engerix-B (hepatitis B vaccine, recombinant)","route":"/drugs/engerix-b/","status":"approved","tldr":"GSK's hepatitis B vaccine, licensed in the United States since 1989 and prequalified by WHO for use in national programmes."},{"id":"recombivax-hb","kind":"drug","name":"Recombivax HB / HBVaxPro (hepatitis B vaccine, recombinant)","route":"/drugs/recombivax-hb/","status":"approved","tldr":"Merck's hepatitis B vaccine, sold as Recombivax HB in the United States since 1986 and as HBVaxPro in the European Union since 2001."},{"id":"heplisav-b","kind":"drug","name":"Heplisav-B (hepatitis B vaccine, recombinant, adjuvanted)","route":"/drugs/heplisav-b/","status":"approved","tldr":"Dynavax's adjuvanted hepatitis B vaccine for adults, licensed in the United States in 2017 and in the European Union in 2021."},{"id":"fendrix","kind":"drug","name":"Fendrix (hepatitis B vaccine, adjuvanted, for kidney failure)","route":"/drugs/fendrix/","status":"approved","tldr":"GSK's adjuvanted hepatitis B vaccine for people from 15 years of age whose kidneys are failing, including people on dialysis, authorised in the European Union since 2005."},{"id":"prehevbrio","kind":"drug","name":"PreHevbrio / PreHevbri (hepatitis B vaccine, adults, withdrawn)","route":"/drugs/prehevbrio/","status":"withdrawn","tldr":"VBI Vaccines' adult hepatitis B vaccine, licensed in the United States in 2021 and the European Union in 2022, and no longer marketed in either."},{"id":"euvax-b","kind":"drug","name":"Euvax B (hepatitis B vaccine, LG Chem)","route":"/drugs/euvax-b/","status":"established","tldr":"LG Chem's hepatitis B vaccine from South Korea, prequalified by WHO since 1996 and available to national immunisation programmes through UN procurement."},{"id":"bevac","kind":"drug","name":"BEVAC hepatitis B vaccine (Biological E)","route":"/drugs/bevac/","status":"approved","tldr":"Biological E's hepatitis B vaccine from India, prequalified by WHO in January 2025 in adult and paediatric presentations."},{"id":"sii-hepatitis-b-vaccine","kind":"drug","name":"Hepatitis B Vaccine (rDNA), Serum Institute of India","route":"/drugs/sii-hepatitis-b-vaccine/","status":"approved","tldr":"The Serum Institute of India's hepatitis B vaccine, prequalified by WHO since 2004 in adult and paediatric presentations."},{"id":"heberbiovac-hb","kind":"drug","name":"Heberbiovac HB (hepatitis B vaccine, Cuba)","route":"/drugs/heberbiovac-hb/","status":"established","tldr":"Cuba's hepatitis B vaccine from the Centro de Ingenieria Genetica y Biotecnologia, prequalified by WHO since 2001."},{"id":"twinrix","kind":"drug","name":"Twinrix / Ambirix (combined hepatitis A and B vaccine)","route":"/drugs/twinrix/","status":"approved","tldr":"GSK's combined vaccine against hepatitis A and hepatitis B, licensed in the European Union since 1996 and the United States since 2001; the hepatitis B part is what protects against liver cancer."},{"id":"cecolin","kind":"drug","name":"Cecolin (bivalent HPV vaccine, Xiamen Innovax)","route":"/drugs/cecolin/","status":"approved","tldr":"A bivalent HPV vaccine made in China by Xiamen Innovax, prequalified by WHO in October 2021, the earlier of the two Chinese HPV vaccines on WHO's list."},{"id":"cecolin-9","kind":"drug","name":"Cecolin 9 (nine-valent HPV vaccine made in E. coli)","route":"/drugs/cecolin-9/","status":"approved","tldr":"A nine-valent HPV vaccine produced in E. coli bacteria, authorised in China in May 2025; three years after vaccination, antibody levels in young women were no lower than with Gardasil 9."},{"id":"walrinvax","kind":"drug","name":"Walrinvax (bivalent HPV vaccine, Yuxi Zerun)","route":"/drugs/walrinvax/","status":"approved","tldr":"A bivalent HPV vaccine made in China by Yuxi Zerun Biotechnology, prequalified by WHO in August 2024."}]}